Catalent Pharma Solutions Appoints New Medication Delivery Solutions President

SOMERSET, N.J.--(BUSINESS WIRE)-- Catalent Pharma Solutions, Inc. announced today the appointment of Barry Littlejohns as President, Medication Delivery Solutions, effective July 5, 2011. Mr. Littlejohns will have full responsibility for Catalent’s Sterile Technologies and Packaging Services segments, including leading more than 2,300 employees at six facilities in both North America and Europe. Mr. Littlejohns will report to John Chiminski, President and CEO of Catalent, and will be based in Catalent’s Somerset, New Jersey global headquarters. Barry Russell, the current incumbent, will simultaneously step down from the role.

Mr. Littlejohns rejoins Catalent after two years at Danish biotechnology company Genmab, where he most recently served as Senior Vice President of Operations and Business Development. Prior to Genmab, Mr. Littlejohns served in a broad variety of leadership roles within Catalent during his twenty year tenure, most recently Vice President of Global Business Operations, Vice President and General Manager of Injectables. Before that, Mr. Littlejohns served in a variety of financial, operational and leadership roles in Catalent’s drug delivery business.

John Chiminski, Catalent’s President and CEO, said, “We are very pleased to welcome Barry back to Catalent in this important role.” Mr. Chiminski continued, “Barry is a proven growth leader, with proven abilities to effectively lead teams and transform operational performance. I expect Barry will help us consolidate and extend our operational improvements in the sterile and packaging areas, and to ensure these businesses reach their full growth potential.”

About Catalent

From drug and biologic development services to delivery technologies to supply solutions, Catalent Pharma Solutions has the deepest expertise, the broadest offerings and the most unique technologies in the industry. With over 75 years of experience, Catalent helps customers get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging solutions. Catalent employs approximately 8,000 people at 24 facilities worldwide and in fiscal year 2010 generated more than $1.7 billion in annual revenue. Catalent is headquartered in Somerset, NJ. For more information, visit www.catalent.com.

more products. better treatments. reliably supplied.™



CONTACT:

Catalent Pharma Solutions, Inc.
Patricia McGee, 732-537-6407
[email protected]

KEYWORDS:   United States  North America  New Jersey

INDUSTRY KEYWORDS:   Health  Biotechnology  Pharmaceutical  Manufacturing  Packaging  Other Manufacturing

MEDIA:

Logo
 Logo

Suggested Articles

Eli Lilly is combining the oncology team at Lilly Research Laboratories with Loxo Oncology and putting a trio of Loxo execs at the helm.

The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors digested the implications of the data.

The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.